login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
BONE BIOLOGICS CORP -CW26 (BBLGW) Stock News
NASDAQ:BBLGW -
10.79
USD
-4.21 (-28.07%)
Last: 8/12/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
News
BBLGW Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Announces Closing of $5.0 Million Public Offering
2 months ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Announces Pricing of $5.0 Million Public Offering
2 months ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Files Patent Application for Bone Regeneration Technology
2 months ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
3 months ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Announces 1-for-6 Reverse Stock Split
10 months ago - By: Bone Biologics
- Mentions:
BBLG
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
a year ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
a year ago - By: Bone Biologics Corporation
- Mentions:
BBLG
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
a year ago - By: Virtual Investor Conferences
- Mentions:
BBLG
Bone Biologics Executives to be Interviewed in a “CEO Chat” by Zacks Small-Cap Research Analyst on June 20th
2 years ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
2 years ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
2 years ago - By: Bone Biologics Corporation
- Mentions:
BBLG
Bone Biologics Announces 1-for-8 Reverse Stock Split
Please enable JavaScript to continue using this application.